Indivior (LSE:INDV) Sale Of Investment : £98.5 Mil (TTM As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Indivior Sale Of Investment?

Indivior's sale of investment for the three months ended in Mar. 2024 was £24.4 Mil. It means Indivior gained £24.4 Mil from selling investments. Indivior's sale of investment for the trailing twelve months (TTM) ended in Mar. 2024 was £98.5 Mil.

Compared with last quarter (£26.9 Mil in Dec. 2023 ), Indivior gained less money from selling investments in Mar. 2024 (£24.4 Mil).

Indivior Sale Of Investment Historical Data

The historical data trend for Indivior's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indivior Sale Of Investment Chart

Indivior Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Sale Of Investment

Get a 7-Day Free Trial

22.17

101.91

Indivior Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Sale Of Investment	Get a 7-Day Free Trial															29.66	22.18	25.05	26.86	24.40

Indivior Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was £98.5 Mil.

Indivior Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Indivior's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Indivior (LSE:INDV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indivior PLC (LSE:INDV) » Definitions » Sale Of Investment

Comparable Companies

Traded in Other Exchanges

INDV:USA INDVl:UK 2IVB:Germany

Address

234 Bath Road, Slough, Berkshire, GBR, SL1 4EE

Website

http://www.indivior.com

Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by the rest of the world. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.